VMP 42276211000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Olanzapine 7.5mg tablets
BNF code 040201060AAABAB
Virtual Therapeutic Moiety Olanzapine
Date identifier became valid 22 Sep 2023
Previous product identifier 321613007
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Olanzapine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 7.500
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Olanzapine 7.5mg tablets (A A H Pharmaceuticals Ltd)
Olanzapine 7.5mg tablets (Accord-UK Ltd)
Olanzapine 7.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Olanzapine 7.5mg tablets (Bristol Laboratories Ltd)
Olanzapine 7.5mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Olanzapine 7.5mg tablets (Krka UK Ltd)
Olanzapine 7.5mg tablets (Medihealth (Northern) Ltd)
Olanzapine 7.5mg tablets (Milpharm Ltd)
Olanzapine 7.5mg tablets (Sigma Pharmaceuticals Plc)
Olanzapine 7.5mg tablets (Teva UK Ltd)
Zalasta 7.5mg tablets (CST Pharma Ltd)
Zyprexa 7.5mg tablets (CST Pharma Ltd)
Zyprexa 7.5mg tablets (Neon Healthcare Ltd)
Zyprexa 7.5mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Olanzapine 7.5mg tablets 28 tablet
Olanzapine 7.5mg tablets 56 tablet

dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.

Feedback